a 3253 has been researched along with 1,4-dihydroxyanthraquinone in 1 studies
| Studies (a 3253) | Trials (a 3253) | Recent Studies (post-2010) (a 3253) | Studies (1,4-dihydroxyanthraquinone) | Trials (1,4-dihydroxyanthraquinone) | Recent Studies (post-2010) (1,4-dihydroxyanthraquinone) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 65 | 0 | 38 |
| Protein | Taxonomy | a 3253 (IC50) | 1,4-dihydroxyanthraquinone (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.065 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fostel, J; Lartey, P; Montgomery, D | 1 |
1 other study(ies) available for a 3253 and 1,4-dihydroxyanthraquinone
| Article | Year |
|---|---|
Comparison of responses of DNA topoisomerase I from Candida albicans and human cells to four new agents which stimulate topoisomerase-dependent DNA nicking.
Topics: Anthraquinones; Antifungal Agents; Camptothecin; Candida albicans; Catecholamines; Dioxins; DNA; DNA Damage; DNA Topoisomerases, Type I; Fungi; HeLa Cells; Humans; Hydroxyindoleacetic Acid; Naphthalenesulfonates; Species Specificity | 1996 |